Online citations, reference lists, and bibliographies.
← Back to Search

Multidisciplinary Care In Amyotrophic Lateral Sclerosis: A 4-year Longitudinal Observational Study.

Eglė Sukockienė, R. Iancu Ferfoglia, A. Truffert, Anne-Chantal Héritier Barras, L. Genton, V. Viatte, I. Leuchter, M. Escher, Ninon S. Horié, A. Poncet, P. Pasquina, D. Adler, J. Janssens
Published 2020 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Over a four-year period, ALS patients complied with the modalities of the multidisciplinary management follow-up without any drop-outs. The multidisciplinary management structure also contributes to increasing the experience and knowledge of the clinicians involved in managing patients suffering from this rare disease.
This paper references
Respiratory failure in amyotrophic lateral sclerosis.
M. Daras (1984)
[Evaluation of anxiety and depression among patients hospitalized on an internal medicine service].
J. Lépine (1985)
The Hospital Anxiety and Depression Scale.
G. Huston (1987)
10.1016/0895-4356(94)00227-H
Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults.
T. Perneger (1995)
10.1016/S0022-510X(99)00210-5
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function
J. Cedarbaum (1999)
Burnand B. Validation et normes du SF-36 dans la population du canton de Vaud. Lausanne: Institut universitaire de médecine sociale et préventive, Raisons de santé
J L Richard (2000)
World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
B R Brooks (2000)
Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
BR Brooks (2000)
Validation et normes du SF-36 dans la population du canton de Vaud. Lausanne: Institut universitaire de médecine sociale et préventive
JL Richard (2000)
10.1016/S0899-9007(00)00553-0
Single prediction equation for bioelectrical impedance analysis in adults aged 20--94 years.
U. Kyle (2001)
10.1002/mus.10090
Disease progression in amyotrophic lateral sclerosis: Predictors of survival
T. Magnus (2002)
10.1136/jnnp.74.9.1258
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000
B. Traynor (2003)
SF-36 health survey: Manual and interpretation guide
J. Ware (2003)
10.4414/SMW.2005.11141
Management of patients with amyotrophic lateral sclerosis.
S. Pautex (2005)
10.1212/01.wnl.0000180717.29273.12
Multidisciplinary ALS care improves quality of life in patients with ALS
J. van den Berg (2005)
10.1212/01.WNL.0000148648.38313.64
The ALSFRSr predicts survival time in an ALS clinic population
P. Kaufmann (2005)
10.1136/jnnp.2005.083402
Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities
A. Chiò (2006)
10.1016/S1474-4422(05)70326-4
Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial
S. Bourke (2006)
10.1136/jnnp.2007.118018
Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study
S. Zoccolella (2007)
10.1016/j.pmr.2008.04.004
The amyotrophic lateral sclerosis center: a model of multidisciplinary management.
Angeli S. Mayadev (2008)
10.1212/01.wnl.0000336653.65605.ac
Increasing incidence of ALS in Canterbury, New Zealand
M. Murphy (2008)
SLAP Registry. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study
S Zoccolella (2008)
10.1136/jnnp.2009.183525
Incidence of amyotrophic lateral sclerosis in Europe
G. Logroscino (2009)
10.1002/14651858.CD007425.pub2
Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease.
L. Ng (2009)
10.3109/17482968.2010.495158
Timelines in the diagnostic evaluation of people with suspected amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) – a 20-year review: Can we do better?
J. D. Mitchell (2010)
10.1212/WNL.0B013E3181D38CED
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
L. Wilkins (2010)
10.1016/j.clnu.2011.06.004
Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients.
L. Genton (2011)
10.1136/jnnp.2010.232637
Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives
P. Bede (2011)
10.3109/17482968.2010.546414
From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): Experiences of people with ALS/MND and family carers – a qualitative study
M. O'Brien (2011)
10.1136/jnnp-2011-300480
Non-invasive ventilation in motor neuron disease: an update of current UK practice
Catherine L O'Neill (2011)
10.3109/17482968.2011.643898
A new member of the multidisciplinary ALS team: The otolaryngologist
A. Rubin (2012)
10.1016/J.NEUROL.2012.10.002
À propos des recommandations de diagnostic et de prise en charge dans les maladies neuromusculaires
J. Pouget (2012)
10.1097/wco.0b013e328356d328
Amyotrophic lateral sclerosis.
A. Ludolph (2012)
10.1007/s00415-012-6681-5
Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009
M. Pugliatti (2012)
10.1136/jnnp-2012-302253
The changing landscape of non-invasive ventilation in amyotrophic lateral sclerosis
S. Bourke (2012)
10.1111/j.1468-1331.2011.03501.x
EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task force
P. Andersen (2012)
10.3109/21678421.2013.776086
Prognostic value of efficiently correcting nocturnal desaturations after one month of non-invasive ventilation in amyotrophic lateral sclerosis: A retrospective monocentre observational cohort study
J. Gonzalez-Bermejo (2013)
10.1038/nrn3430
The changing scene of amyotrophic lateral sclerosis
W. Robberecht (2013)
10.1186/1471-2377-13-19
Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset
O. Kano (2013)
10.1159/000351153
Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature
A. Chiò (2013)
10.3109/17482968.2012.690419
The natural history of motor neuron disease: Assessing the impact of specialist care
T. Aridegbe (2013)
10.1186/1471-2377-13-84
Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options
S. Körner (2013)
10.4414/smw.2013.13830
Is tracheostomy still an option in amyotrophic lateral sclerosis? Reflections of a multidisciplinary work group.
Anne-Chantal Héritier Barras (2013)
10.1371/journal.pone.0074733
Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995–2010
J. Rooney (2013)
10.3109/21678421.2013.855790
Non-invasive ventilation effectiveness and the effect of ventilatory mode on survival in ALS patients
J. Sancho (2014)
10.1136/jnnp-2014-309601
A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland
J. Rooney (2014)
10.3109/21678421.2014.971811
Need and value of case management in multidisciplinary ALS care: A qualitative study on the perspectives of patients, spousal caregivers and professionals
M. Bakker (2015)
10.1371/journal.pone.0131965
Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases
Susan T. Paulukonis (2015)
10.1016/j.nut.2015.06.005
Should patients with ALS gain weight during their follow-up?
Anne-Chantal Héritier (2015)
10.1186/s12913-015-1229-x
Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study
Marie Galvin (2015)
10.1007/s00415-016-8290-1
The frontotemporal syndrome of ALS is associated with poor survival
Rosanne Govaarts (2016)
10.1007/s00415-016-8313-y
Factors predicting survival in ALS: a multicenter Italian study
A. Calvo (2016)
10.1111/ene.12941
Evaluation of the application of the European guidelines for the diagnosis and clinical care of amyotrophic lateral sclerosis (ALS) patients in six French ALS centres
B. Marin (2016)
10.1038/nrneurol.2016.111
Supportive and symptomatic management of amyotrophic lateral sclerosis
Esther V Hobson (2016)
10.1016/j.jocn.2015.12.037
Prognostic factors for survival in patients with amyotrophic lateral sclerosis: analysis of a multi-centre clinical trial
E. Yates (2016)
10.1161/CIRCULATIONAHA.115.017719
Introduction to the Analysis of Survival Data in the Presence of Competing Risks
P. Austin (2016)
10.1136/jnnp-2015-312606
Reduced survival in patients with ALS with upper airway obstructive events on non-invasive ventilation
M. Georges (2016)
10.2147/DNND.S135748
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis
M. Hinchcliffe (2017)
10.1080/21678421.2017.1349151
The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison
Sarah Martin (2017)
10.1016/S1474-4422(17)30115-1
Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
Koji Abe (2017)
Edaravone (MCI-186) ALS 19 Study Group. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial
K Abe (2017)
10.1016/j.clnu.2017.09.003
ESPEN guideline clinical nutrition in neurology.
R. Burgos (2018)
10.1177/1049909117735832
End-of-life Characteristics and Palliative Care Provision for Patients With Motor Neuron Disease
Hon Wai Benjamin Cheng (2018)
10.1007/s00415-018-8778-y
Riluzole and other prognostic factors in ALS: a population-based registry study in Italy
J. Mandrioli (2018)
10.1002/mus.26149
Clinical characteristics of long‐term survival with noninvasive ventilation and factors affecting the transition to invasive ventilation in amyotrophic lateral sclerosis
T. Hirose (2018)
10.2147/JMDH.S177563
Patient perspectives on transitioning to amyotrophic lateral sclerosis multidisciplinary clinics
K. Schellenberg (2018)
10.1159/000498972
Assessing Inspiratory Muscle Strength for Early Detection of Respiratory Failure in Motor Neuron Disease: Should We Use MIP, SNIP, or Both?
J. Janssens (2019)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar